Magnetic

This page shows the latest Magnetic news and features for those working in and with pharma, biotech and healthcare.

Sanofi highlights MS drug data as it swings to a loss in Q4

SAR442168 – a BTK inhibitor licensed from Principia Biopharma that can cross the blood brain barrier – significantly reduced disease activity associated with MS measured using magnetic resonance imaging (MRI) in the phase

Latest news

New data backs GeNeuro’s MS drug after Servier exit

GeNeuro opted to continue dosing patients in the open-label follow-up, and now says temelimab provided continued relative improvements in neurodegeneration measured by magnetic resonance imaging (MRI), including a reduction
New data backs Merck’s segue into MS with BTK inhibitor

detected using magnetic resonance imaging (MRI).
J&J therapy for suicidal depressives 'a breakthrough', says FDA

Currently the only approved fast-acting treatments for MDD are transcranial magnetic stimulation and electro-conductive therapy.
Sanofi posts positive data for MS drug Aubagio

Magnetic resonance imaging (MRI) was used in the trial, called TEMSO, to assess changes in brain volume from baseline in patients with Aubagio (teriflunomide) 14mg, 7mg or placebo.
Takeda's once-weekly DPP-4 inhibitor cleared in first market

Bayer has been granted approval for magnetic resonance imaging (MRI) agent Gadovist (gadobutrol) injection, which has been on the market since 1998 in Europe and is sold in more than 100

More from news
Approximately 0 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Oral biologics delivery still elusive

The technology came to prominence after Google announced it was using it to develop a pill that would deliver magnetic nanoparticles that would seek out early signs of cancer.
Country report: The healthcare market in Brazil

Examples of products in these groups are magnetic resonance imaging equipment, orthopaedic implants and glucose self-testing devices.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Rare Disease Day 2019: A patient perspective on primary sclerosing cholangitis

I was eventually referred to a liver specialist and underwent an MRI [magnetic resonance imaging] scan.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Account Director – Creative Healthcare Communications: Competative

Healthcare Account Director: Competitive

Healthcare Lead Copywriter: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Medical Editor: Competitive

Commercial Finance Director, Healthcare Marketing Communications...: up to £90K

Healthcare Senior Account Manager: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

PMHub

Add my company

Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Mistrust in medical research: a patient perspective: The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease: Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients: We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...